跳至主要内容
临床试验/CTRI/2025/08/092839
CTRI/2025/08/092839尚未招募不适用

Comparative study of efficacy of Jaloukavcharan and Siravyadha in Sirajgranthi W.s.r to Varicose Vein

Dr Harmeet Kour1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年8月23日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
Does Jaloukavcharan show more effect in comparison to Siravyadha in the management of Sirajgranthi (Varicose Vein)

研究概览

简要总结

Varicose veins are the disease characterized by dilated, tortuous, elongated veins. it is more prevalent in females (25-30%) than males (15%). lack of proper exercise , prolonged standing or sitting, increasing age, heavy weightlifting, multiple pregnancies, high blood pressure are the predisposing factors. it is one of the common problems for which patients visit the Ayurvedic hospitals. Acharya Sushruta has described that vitiated Vat when renders in Siras it causes pain, contraction and fullness of blood vessels. This disease has been named as Kutilasira or Sirajgranthi. Acharya Sushruta has mentioned Raktmokshana in the treatment of Sirajgranthi. it is considered as Ardha Chikitsa of Shalyatantra and is said to provide immediate results. Thus Leech therapy and Siravyadha can be a cheaper and effective way to deal with Varicose vein. this treatment improve microcirculation and nutrition to sk.in and surrounding tissues, simultaneously it helps in reducing extra load on veins and blood pooling in distended vessels. Thus this study will prove to effective, safe and cost effective treatment in treating Varicose vein.

A total of 90 patients are selected and randomly divided in 2 groups.

Group 1 - 45 patients will recieve four sittings of Leech therapy (Jaloukavcharan) with a gap of one week.

Group 2 - 45 patients will be treated with Siravyadha with a gap of one week

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1 Patients with clinical features of varicose veins.
  • 2 Age group of 18-70 years irrespective of gender.
  • 3 Patient indicated for Jaloukavcharan and Siravyadha.

排除标准

  • 1 Presence of any tumor as a cause of varicose veins.
  • 2 Congenital disorders.
  • 3 Blood clotting disorders.
  • 4 Patients on prolonged anti-coagulant drugs.
  • 5 Patients suffering from autoimmune disorders.
  • 6 Children less than 18 or elderly above 70 years.
  • 7 Patient not willing for leech therapy and Siravyadha.
  • 8 Patients having TB, severe anaemia, obesity, venous ulcer.
  • 9 Patient contraindicated for Jaloukavcharan and Siravyadha.
  • 10 Hb less than 10gm %.

结局指标

主要结局

Does Jaloukavcharan show more effect in comparison to Siravyadha in the management of Sirajgranthi (Varicose Vein)

时间窗: 30 days

次要结局

  • -To promote the safe, cost effective and traditional treatment of management of Sirajgranthi(-To promote the innovative treatment of Sirajgranthi)

研究者

发起方
Dr Harmeet Kour
申办方类型
Other [Self sponsor]
责任方
Principal Investigator
主要研究者

Dr Anita Patel

Swami Narayan Ayurvedic College Kalol, Gandhinagar, Gujarat

研究点 (1)

Loading locations...

相似试验